FlaggedRx← Medication recall checkHome
Class II · ModerateActive recall

Haloperidol Decanoate

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberA240467B, EXP 07/31/2026
Where it was soldNationwide in the USA
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Lack of assurance of sterility. Bacterial contamination detected in some media fill units

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Made bySomerset Therapeutics Limited, 54/1, Boodhihal Village, Nelamangala, Bangalore - 562123, Karnataka, India, Manufactured for: BluePoint Laboratories foreign manufacturer
Brand nameHALOPERIDOL DECANOATE
Generic nameHALOPERIDOL DECANOATE
Active ingredient(s)HALOPERIDOL DECANOATE
Distributed by / forBluePoint Laboratories
NDC68001-580-41
Show the full FDA record
Full product labelHaloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by Somerset Therapeutics Limited, 54/1, Boodhihal Village, Nelamangala, Bangalore - 562123, Karnataka, India, Manufactured for: BluePoint Laboratories, NDC 68001-580-41.
Recalling firmAmerisource Health Services LLC
DistributionNationwide in the USA
Quantity2,110 vials
Recall initiated2025-04-02
Report date2025-04-30
Recall completed
Recall numberD-0367-2025
ClassificationClass II
FDA statusOngoing
Origin on fileColumbus OH United States

Related

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.